期刊文献+

胃力康治疗功能性消化不良102例临床分析

Clinical analysis of Weilikang for treating 102 cases of functional dyspepsia
下载PDF
导出
摘要 目的观察胃力康对功能性消化不良所致腹胀的疗效。方法将功能性消化不良102例纳入研究,予以胃力康10 g,每天3次,冲服,疗程4周。观察治疗前后腹胀积分改变。所有患者治疗前后进行水负荷试验。结果胃力康可明显改善功能性消化不良患者的腹胀症状,治疗2周及4周腹胀症状积分均明显下降(P<0.05)。治疗后,患者最大饮水量明显增加(P<0.05)。其对腹胀的总有效率为83.3%。治疗过程中无不良反应。结论胃力康是治疗功能性消化不良患者腹胀症状安全、有效的药物。 Objective To observe the effect of Weilikang in treating abdominal distension caused by functional dyspepsia. Methods 102 cases of fuctional dyspepsia were enrolled in this research and were orally given Weilikang 10 g,three times a day for 4 weeks.The change of abdominal distension scores were observed before and after treatment. All cases were per- formed the water load trial. Results Weilikang could obviously relieve the symptom of abdominal distension in the patients with functional dyspepsia. After 2-week and 4-week treatment, the scores of abdominal distension were obviously decreased (P〈0.05). After therapy, maximum amount of water intake was increased (P〈0.05).The total effective rate for abdominal distension was 83.3% ,and there was no adverse reactions during the whole therapy. Conclusion Weilikang is quite safe and effective drug for treating abdominal distension of functional despepsia.
出处 《现代医药卫生》 2012年第14期2108-2108,2110,共2页 Journal of Modern Medicine & Health
关键词 消化不良/药物疗法 肠胃胀气 胃力康 功能性消化不良 腹胀 药物治疗 Dyspepsia/therapy,drug Flatulence Weilikang Functional despepsia Abdominal distension Medication
  • 相关文献

参考文献9

二级参考文献27

  • 1李章,高镇松,林和文,杨壁辉.功能性消化不良与心理因素的关系及抗抑郁药辅助治疗效应[J].中国临床康复,2004,8(24):4953-4955. 被引量:27
  • 2WU CY, Chou LT, Chen HP, et al. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia[ J].Hepatogastroenterology, 2003,50 ( 49 ) : 278.
  • 3Talley N J, Verlinden M ,Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia[J]. Am J Gastroentero1,2001,96 ( 1 ) :442.
  • 4Malfertheiner P. Current concepts in dyspepsia: a world perspective [J]. Eur J Gastroenterol Hepatol, 1999,11 ( Suppl 1 ) :25-29.
  • 5Talley N J, Stanghellinni V, Heading RC, et al. Functional gastrodud disorders[ J]. J Gut, 1999,45 ( Suppl 12 ) :37-42.
  • 6WU CY, Chou LT, Chen HP, et al. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia[J].Hepatogastroent erology, 2003,50 ( 49 ) : 278.
  • 7Talley N J, Verlinden M ,Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia[ J]. Am J Gastroenterol,2001,96 ( 1 ) :442.
  • 8Malfertheiner P. Current concepts in dyspepsia: a world perspective[ J]. Eur J Gastroenterol Hepatol, 1999,11 ( Suppl 1 ) :25-29.
  • 9Iwanaga Y,Miyashita N,Morikawa K,et al.A novel wate-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity.Gastroenterology,1990,99:401-408.
  • 10Talley NJ,Stanghellini V,Heading RC,et al.Functional gastroduodenal disorde.Gut,1999,45(Suppl 2):37-42.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部